Study Summary
This trial will test how effective augmented-reality (AR) glasses are at helping people with Parkinson's Disease reduce their gait freezing (FOG) by providing digital cues that only the wearer can see.
- Parkinson's Disease
- Neurologic Gait Disorders
- Movement Disorders
- Gait Instability
- Festinating Gait
Treatment Effectiveness
Effectiveness Progress
Study Objectives
2 Primary · 6 Secondary · Reporting Duration: For each arm, during the single-day research visit only.
Trial Safety
Trial Design
1 Treatment Group
Augmented-Reality Visual Cues
1 of 1
Experimental Treatment
36 Total Participants · 1 Treatment Group
Primary Treatment: Augmented-Reality Visual Cues · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
What are the chief ambitions of this clinical experiment?
"This clinical trial aims to measure Percent Time Freezing over the course of a single-day research visit. Secondary outcomes include Step Cadence, an index derived from body-worn wireless sensors that serves as an indicator of dysfunction; Freezing Index, another marker determined by kinematic recordings taken with these sensors; and Gait Velocity which is also indicative of gait disorder due to its correlation with sensor readings." - Anonymous Online Contributor
Is enrollment available for this clinical trial at present?
"The details available on clinicaltrials.gov suggest that this medical trial is not presently seeking participants, as the last update was posted on November 4th 2022. Nonetheless, there are 1539 other trials actively recruiting patients at present." - Anonymous Online Contributor